Found 11 matching trials
Busulfan, Melphalan, and Stem Cell Transplant After Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma
PHASE1This pilot clinical trial studies busulfan, melphalan, and stem cell transp...
Location
Children's Hospital of Alabama
A Single-arm, Prospective Study of TBI + BUMEL As a Conditioning Regimen for Salvage HSCT in Patients with R/R AML
NAAcute myeloid leukemia (AML) is one of the hematologic malignancies, for wh...
Location
Hematology Department, The First Affiliated Hospital of Soochow University
A Single-Arm, Prospective Study of TBI+BUMEL as Conditioning for SCT2 in Patients With Malignant Hematologic Diseases
NAEach year, over 20,000 patients in China undergo hematopoietic stem cell tr...
Location
Hematology Department, The First Affiliated Hospital of Soochow University
Busulfan & Melphalan Conditioning for Autologous Stem Cell Transplant (ASCT) and Lenalidomide Maintenance
PHASE2A number of strategies have been proposed to improve the outcome of ASCT. T...
Location
Cross Cancer Institute 11560 University Ave
Bortezomib (Velcade®), Lenalidomide (Revlimid®) and IV Busulfan (Busilvex®) in Patients Under 65 Years Old
PHASE3This protocol is a national, multicenter, comparative, open-label, randomiz...
Location
Hospital Son Espases (Son Dureta)
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
PHASE3This phase III trial studies iobenguane I-131 or lorlatinib and standard th...
Location
Children's Hospital of Alabama
Protocol for the Treatment of Metastatic Ewing Sarcoma
PHASE2Study for the treatment of metastatic Ewing sarcoma with high doses chemoth...
Location
Centro di Riferimento Oncologico - Unit of Medical Oncology
Pethema Multiple Myeloma 2000
PHASE3The study objectives are to investigate the toxicity and the BUMEL response...
Location
Multiple Locations
First-line Treatment of Ewing Tumours With Primary Extrapulmonary Dissemination in Patients From 2 to 50 Years (CombinaiR3)
PHASE2Ewing's sarcoma and related tumours (ESFT) are rare tumours, with a peak in...
Evaluation of 2 Intensification Treatment Strategies for Neuroblastoma Patients With a Poor Response to Induction
PHASE2The main objective is to evaluate the efficacy of two intensified consolida...
Location
Medizinische Universität Innsbruck